糖基化磷脂酰肌醇特異性磷脂酶D1(GPLD1)活性蛋白
Active Glycosylphosphatidylinositol Specific Phospholipase D1 (GPLD1)
GPIPLD; GPIPLDM; PIGPLD; PIGPLD1; Glycoprotein phospholipase D; Glycosyl-phosphatidylinositol-specific phospholipase D
- 編號(hào)APH975Hu01
- 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)6.9
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1728 ¥ 4320¥ 8640¥ 25920¥ 64800
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPH975Hu01 | 糖基化磷脂酰肌醇特異性磷脂酶D1(GPLD1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APH975Hu01 | 糖基化磷脂酰肌醇特異性磷脂酶D1(GPLD1)活性蛋白 | Cell?culture;?Activity?Assays. |
PAH975Hu01 | 糖基化磷脂酰肌醇特異性磷脂酶D1(GPLD1)多克隆抗體 | IHC |
MAH975Hu21 | 糖基化磷脂酰肌醇特異性磷脂酶D1(GPLD1)單克隆抗體 | WB; IHC; ICC; IP. |
SEH975Hu | 糖基化磷脂酰肌醇特異性磷脂酶D1(GPLD1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMH975Hu | 糖基化磷脂酰肌醇特異性磷脂酶D1(GPLD1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
International Journal of Clinical and Experimental Medicine Int J Clin Exp Med. 2012; 5(4): 306–309. | Plasma glycosylphosphatidylinositol phospholipase D (GPI-PLD) and abdominal aortic aneurysm[PubMed: PMC3443889] |
J Endocrinol Invest | Serum glypican4 and glycosylphosphatidylinositol-specific phospholipase D levels are associated with adipose tissue insulin resistance in obese subjects with …[Pubmed: 32816247] |